| Development and validation of an individualized immune prognostic signature in early-stage nonsquamous non–small cell lung cancer B Li, Y Cui, M Diehn, R Li JAMA oncology 3 (11), 1529-1537, 2017 | 326 | 2017 |
| The Immune Subtypes and Landscape of Squamous Cell CarcinomaImmune Landscape of Squamous Cell Carcinoma B Li, Y Cui, DK Nambiar, JB Sunwoo, R Li Clinical Cancer Research 25 (12), 3528-3537, 2019 | 94 | 2019 |
| Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with dysregulated signaling pathways and poor survival in breast cancer J Wu, B Li, X Sun, G Cao, DL Rubin, S Napel, DM Ikeda, AW Kurian, R Li Radiology 285 (2), 401, 2017 | 72 | 2017 |
| Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular PathwaysImaging Subtypes of Breast Cancer J Wu, Y Cui, X Sun, G Cao, B Li, DM Ikeda, AW Kurian, R Li Clinical Cancer Research 23 (13), 3334-3342, 2017 | 70 | 2017 |
| Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway H Liu, ZQ Yan, B Li, SY Yin, Q Sun, JJ Kou, D Ye, K Ferns, HY Liu, SL Liu Journal of ovarian research 7 (1), 1-9, 2014 | 53 | 2014 |
| Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast CancerPredictive Biomarker for Breast Radiotherapy Y Cui, B Li, EL Pollom, KC Horst, R Li Clinical Cancer Research 24 (19), 4754-4762, 2018 | 40 | 2018 |
| Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit B Li, Y Jiang, G Li, GA Fisher Jr, R Li JCI insight 5 (9), 2020 | 35 | 2020 |
| Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease MJ Mason, C Schinke, CLP Eng, F Towfic, F Gruber, A Dervan, BS White, ... Leukemia 34 (7), 1866-1874, 2020 | 28 | 2020 |
| A quantitative CT imaging signature predicts survival and complements established prognosticators in stage I non-small cell lung cancer J Lee, B Li, Y Cui, X Sun, J Wu, H Zhu, J Yu, MF Gensheimer, BW Loo Jr, ... International Journal of Radiation Oncology* Biology* Physics 102 (4), 1098-1106, 2018 | 22 | 2018 |
| A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation X Zhou, B Li, Y Zhang, Y Gu, B Chen, T Shi, L Ao, P Li, S Li, C Liu, Z Guo Breast cancer research and treatment 142 (3), 505-514, 2013 | 17 | 2013 |
| Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC J Lee, Y Cui, X Sun, B Li, J Wu, D Li, MF Gensheimer, BW Loo, M Diehn, ... European radiology 28 (2), 736-746, 2018 | 15 | 2018 |
| Single-cell spatial analysis of tumor and immune microenvironment on whole-slide image reveals hepatocellular carcinoma subtypes H Wang, Y Jiang, B Li, Y Cui, D Li, R Li Cancers 12 (12), 3562, 2020 | 12 | 2020 |
| Complete genome sequence of Salmonella enterica subspecies arizonae str. RKS2983 CX Wang, SL Zhu, XY Wang, Y Feng, B Li, YG Li, RN Johnston, GR Liu, ... Standards in Genomic Sciences 10 (1), 1-7, 2015 | 10 | 2015 |
| Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment B Li, Y Li, XY Wang, ZQ Yan, H Liu, GR Liu, SL Liu American Journal of Cancer Research 5 (2), 726, 2015 | 10 | 2015 |
| Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer C Jin, Y Jiang, H Yu, W Wang, B Li, C Chen, Q Yuan, Y Hu, Y Xu, Z Zhou, ... British Journal of Surgery 108 (5), 542-549, 2021 | 8 | 2021 |
| Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers X Zhou, T Shi, B Li, Y Zhang, X Shen, H Li, G Hong, C Liu, Z Guo PLoS One 8 (7), e70017, 2013 | 8 | 2013 |
| Deconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patients L Qi, B Li, Y Dong, H Xu, L Chen, H Wang, P Li, W Zhao, Y Gu, C Wang, ... PLoS One 9 (6), e100934, 2014 | 7 | 2014 |
| Alternative splicing-based differences between hepatocellular carcinoma and intrahepatic cholangiocarcinoma: genes, immune microenvironment, and survival prognosis D Luo, D Zhao, M Zhang, C Hu, H Li, S Zhang, X Chen, L Huttad, B Li, ... Frontiers in oncology 11, 2021 | 4 | 2021 |
| B cell-related gene signature and cancer immunotherapy response A Lundberg, B Li, R Li British Journal of Cancer 126 (6), 899-906, 2022 | 2 | 2022 |
| Predicting High-Risk Individuals for Common Diseases Using Multi-Omics and Epidemiological Data D Chowdhury, X Zhou, B Li, Y Zhang, WK Cheung, A Lu, L Zhang Frontiers in Genetics 12, 2021 | 1 | 2021 |
Ruijiang LiStanford UniversityVerified email at stanford.edu
